In contrast, in people with type 2 diabetes, abnormalities in insulin and glucagon secretion rates persisted during hyperglycemia — in the latter case, to the point that hyperglycemia and hyperinsulinemia are insufficient to suppress EGP. This evidence concerns the gene INS and Hyperinsulinemia.